6506--Intent to Sole Source - BLOOD, BLOOD PRODUCTS, AND APHERESIS

The Department of Veterans Affairs Veterans Health Administration, Veterans Integrated Service Network 2 has published a Notice of Intent to Award a Sole Source Contract for blood and blood products. The contracting office intends to award this requirements contract exclusively to Greater Metropolitan Community Blood Services to supply blood and blood components to hospitalized veterans at James J. Peters VA Medical Center in the Bronx and the New York Harbor Healthcare System sites in Manhattan and Brooklyn. This special notice is solicitation number 36C24226Q0392 and was posted on March 3, 2026. The contract will operate as a single order period spanning five years with five separate annual pricing periods from October 1, 2026 through September 30, 2031. The notice provides an opportunity for interested parties to submit expressions of interest and demonstrate capability to serve as an alternative supplier.

The primary objective of this notice is to alert potential contractors to the government's intent to sole source this contract while allowing interested parties to challenge the award by demonstrating comparable capability. Interested contractors must submit detailed capability statements including pricing and technical data by the March 18, 2026 deadline at 4:00 PM Eastern Time to the contracting office. The government requires an extensive range of blood products including red blood cells (leukocyte reduced), fresh frozen plasma, cryoprecipitate, platelets, and specialized apheresis products with various enhancements such as irradiation, CMV negative processing, and HLA matching. Contractors must be capable of meeting demanding delivery requirements including 2-hour emergency order delivery and 8-hour supplemental order delivery, along with weekend and holiday pickup options. Interested parties should direct inquiries to Contract Specialist Vivian Lu at Vivian.Lu4@va.gov or 773-999-2988, and only organizations with proven blood product distribution and processing capabilities would be considered eligible to participate in this procurement.